Echo IQ is trading 31.36% up now at A$0.78 after its September 17 FDA update outlined a clear path toward EchoSolv HF clearance over coming quarters.
- The company identified an administrative appeal, FDA Ombudsman review, and potential new 510(k) submission.
- FDA concerns involved statistical analysis, not the deviceβs technology or core functionality.
- No separate September 21 announcement or explicit price-causation statement was found.